These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32989896)

  • 1. The synergy of germline C634Y and V292M RET mutations in a northern Chinese family with multiple endocrine neoplasia type 2A.
    Yang Z; Qi X; Gross N; Kou X; Bai Y; Feng Y; Wang B; Zafereo ME; Li G; Sun C; Li H; Chen X; Huang Z
    J Cell Mol Med; 2020 Nov; 24(22):13163-13170. PubMed ID: 32989896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A/familial medullary thyroid carcinoma family.
    Qi XP; Ma JM; Du ZF; Ying RB; Fei J; Jin HY; Han JS; Wang JQ; Chen XL; Chen CY; Liu WT; Lu JJ; Zhang JG; Zhang XN
    PLoS One; 2011; 6(5):e20353. PubMed ID: 21655256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RET proto-oncogene genetic screening of families with multiple endocrine neoplasia type 2 optimizes diagnostic and clinical management in China.
    Qi XP; Chen XL; Ma JM; Du ZF; Fei J; Yang CP; Cheng J; Song QZ; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Liu WT; Zhao Y; Chen CY; Jiang HL; Ke HP; Zhang XN
    Thyroid; 2012 Dec; 22(12):1257-65. PubMed ID: 23210566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
    Zhou YL; Zhu SX; Li JJ; Liu JB; Yin M; Xiao BY; Yu CL; Wang LM; Gu LQ; Cui B; Ning G; Li XY; Zhao YJ
    Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China.
    Qi XP; Zhao JQ; Du ZF; Yang RR; Ma JM; Fei J; Cheng J; Han JS; Jin HY; Chen ZG; Wang JQ; Yang YP; Ying RB; Chen XL; Liu WT; Zhao Y; Jiang HL; Zhang XN
    Eur J Surg Oncol; 2013 Sep; 39(9):1007-12. PubMed ID: 23849459
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Qi XP; Jin BY; Li PF; Wang S; Zhao YH; Cao ZL; Yu XH; Cheng J; Fang XD; Zhao JQ
    Thyroid; 2019 Oct; 29(10):1447-1456. PubMed ID: 31364476
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives.
    Wang J; Zhang B; Liu W; Zhang Y; Di X; Yang Y; Yan D
    Fam Cancer; 2016 Jan; 15(1):99-104. PubMed ID: 26254625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype-phenotype correlation: an appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilian families.
    Valente FO; Dias da Silva MR; Camacho CP; Kunii IS; Bastos AU; da Fonseca CC; Simião HP; Tamanaha R; Maciel RM; Cerutti JM
    J Endocrinol Invest; 2013 Dec; 36(11):975-81. PubMed ID: 23723040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
    Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation.
    González-Yebra B; Medrano ME; Mantilla A; Palma V; Colin C; Hernández DM; Tapia J; Dawson B; Salcedo M
    Endocr Pathol; 2003; 14(1):71-80. PubMed ID: 12746565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
    Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.
    Qi XP; Zhao JQ; Fang XD; Lian BJ; Li F; Wang HH; Cao ZL; Zheng WH; Cao J; Chen Y
    BMC Cancer; 2021 Apr; 21(1):369. PubMed ID: 33827484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization.
    Castellone MD; Verrienti A; Magendra Rao D; Sponziello M; Fabbro D; Muthu M; Durante C; Maranghi M; Damante G; Pizzolitto S; Costante G; Russo D; Santoro M; Filetti S
    Clin Endocrinol (Oxf); 2010 Oct; 73(4):529-34. PubMed ID: 20039896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RET proto-oncogene mutations are restricted to codon 634 and 618 in Korean families with multiple endocrine neoplasia 2A.
    Chung YJ; Kim HH; Kim HJ; Min YK; Lee MS; Lee MK; Kim KW; Ki CS; Kim JW; Chung JH
    Thyroid; 2004 Oct; 14(10):813-8. PubMed ID: 15588376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare RET Variant p.D707E in a Chinese Pedigree with Hereditary Medullary Thyroid Carcinoma.
    Zhang L; Li X; Li Q; Ge S; Chen M; Huang S; Chen B; Li P; Teng B; Xu J; Zhao S; Qi F; Zhang Y
    Pathobiology; 2017; 84(3):152-160. PubMed ID: 27798940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High penetrance of pheochromocytoma associated with the novel C634Y/Y791F double germline mutation in the RET protooncogene.
    Toledo RA; Wagner SM; Coutinho FL; Lourenço DM; Azevedo JA; Longuini VC; Reis MT; Siqueira SA; Lucon AM; Tavares MR; Fragoso MC; Pereira AA; Dahia PL; Mulligan LM; Toledo SP
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1318-27. PubMed ID: 20080836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotype-specific progression of hereditary medullary thyroid cancer.
    Machens A; Lorenz K; Weber F; Dralle H
    Hum Mutat; 2018 Jun; 39(6):860-869. PubMed ID: 29656518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characterization of RET proto-oncogene C634Y mutation in a Moroccan family with multiple endocrine neoplasia type 2A].
    Benazzouz B; Chraïbi A; Doghmi Y; El Bacha S; Boutayeb S; Kadiri A; Hilal L
    Ann Endocrinol (Paris); 2006 Mar; 67(1):21-6. PubMed ID: 16596053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D.
    Qi XP; Zhao JQ; Chen ZG; Cao JL; Du J; Liu NF; Li F; Sheng M; Fu E; Guo J; Jia H; Zhang YM; Ma JM
    Oncotarget; 2015 Oct; 6(32):33993-4003. PubMed ID: 26356818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Homozygous RET K666N Genotype With an MEN2A Phenotype.
    Jaber T; Hyde SM; Cote GJ; Grubbs EG; Giles WH; Stevens CA; Dadu R
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1269-1272. PubMed ID: 29408964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.